Cargando…

Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review

A 72-year-old female and a 57-year-old male with chronic hepatitis C were treated with a combination therapy of pegylated interferon (PEG-IFN)-α 2a (180 μg s.c. once a week) and ribavirin (1,000 mg orally daily). This resulted in the destruction of melanocytes at the injection site in both patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, V., Bansal, M., Girard, L., Arya, S., Valluri, A.
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978742/
https://www.ncbi.nlm.nih.gov/pubmed/21076689
http://dx.doi.org/10.1159/000320207